2024. Drying of Opzelura® (Ruxolitinib) Cream 1.5%: Implications for Clinical and Real-World Use. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s454. DOI:https://doi.org/10.25251/skin.8.supp.454.